Authors: Magnani, C Passerini, E Pasini, B Regolo, P Fiore, T Libroia, A Verga, U Ferrari, M

Citation: C. Magnani et al., Search for germline mutations by DGGE in Italian von Hippel-Lindau patients, CONTR NEPHR, 136, 2001, pp. 271-280

Authors: Birindelli, S Perrone, F Oggionni, M Lavarino, C Pasini, B Vergani, B Ranzani, GN Pierotti, MA Pilotti, S

Citation: S. Birindelli et al., Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors, LAB INV, 81(6), 2001, pp. 833-844

Authors: Della Torre, G Pasini, B Frigerio, S Donghi, R Rovini, D Delia, D Peters, G Huot, TJG Bianchi-Scarra, G Lantieri, F Rodolfo, M Parmiani, G Pierotti, MA

Citation: G. Della Torre et al., CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation, BR J CANC, 85(6), 2001, pp. 836-844

Authors: Narod, SA Brunet, JS Ghadirian, P Robson, M Heimdal, K Neuhausen, SL Stoppa-Lyonnet, D Lerman, C Pasini, B de los Rios, P Weber, B Lynch, H

Citation: Sa. Narod et al., Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study, LANCET, 356(9245), 2000, pp. 1876-1881

Authors: Bongarzone, I Vigano, E Alberti, L Mondellini, P Uggeri, M Pasini, B Borrello, MG Pierotti, MA

Citation: I. Bongarzone et al., The Glu632-Leu633 deletion in cysteine rich domain of Bet induces constitutive dimerization and alters the processing of the receptor protein, ONCOGENE, 18(34), 1999, pp. 4833-4838

Authors: Pasini, B Pierotti, MA

Citation: B. Pasini et Ma. Pierotti, Familial breast and ovarian cancer: Genetic counseling and clinical management in Italy, DIS MARKER, 15(1-3), 1999, pp. 41-43